Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy

SIMPLE SUMMARY: Urothelial bladder carcinoma entails significant health costs due to the high recurrence rates and poor response to standard cisplatin-based treatment. The glycolytic phenotype is a hallmark of proliferating cancer cells, but research is needed to validate the glycolysis-related prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Afonso, Julieta, Gonçalves, Céline, Costa, Marta, Ferreira, Débora, Santos, Lúcio, Longatto-Filho, Adhemar, Baltazar, Fátima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913750/
https://www.ncbi.nlm.nih.gov/pubmed/36765947
http://dx.doi.org/10.3390/cancers15030982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913750/
https://www.ncbi.nlm.nih.gov/pubmed/36765947
http://dx.doi.org/10.3390/cancers15030982

Ejemplares similares